<DOC>
	<DOCNO>NCT01822288</DOCNO>
	<brief_summary>Menopausal syndromes include somatic symptom , psychosomatic symptom , sexual dysfunction even urinary symptom . Hormone therapy ( HT ) widely use control menopausal symptom . Common HT menopausal syndrome intact uterus include tibolone , estradiol valerate ( E2V ) 1mg &amp; medroxyprogesterone acetate ( MPA ) 2.5 mg , conjugate equine estrogens &amp; MPA . However , literature mention therapeutic effect tibolone , lack comparison research therapeutic effect somatic symptom , psychosomatic symptom , sexual dysfunction even urinary symptom . The knowledge therapeutic effect important choose suitable medication . Therefore , aim study assess therapeutic effect somatic symptom , psychosomatic symptom , sexual dysfunction even urinary symptom tibolone E2V/MPA .</brief_summary>
	<brief_title>The Impact Hormone Therapy Lower Urinary Tract Symptoms , Sexual Function Psychosomatic Disorder</brief_title>
	<detailed_description />
	<mesh_term>Lower Urinary Tract Symptoms</mesh_term>
	<mesh_term>Psychophysiologic Disorders</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Tibolone</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Medroxyprogesterone</mesh_term>
	<mesh_term>Medroxyprogesterone Acetate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>All female patient intact uterus seek medical treatment menopausal syndrome patient gynecologic breast cancer</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Menopause</keyword>
	<keyword>Tibolone</keyword>
	<keyword>Estradiol</keyword>
	<keyword>Hormone therapy</keyword>
</DOC>